Precigen
PGEN
138 hedge funds and large institutions have $124M invested in Precigen in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 17 closing their positions.
7,139% more call options, than puts
Call options by funds: $4.13M | Put options by funds: $57K
47% more capital invested
Capital invested by funds: $84.8M → $124M (+$39.7M)
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
4% more funds holding
Funds holding: 133 → 138 (+5)
1.43% more ownership
Funds ownership: 25.88% → 27.31% (+1.4%)
21% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$5.02M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$733K |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$646K |
| 5 |
BlackRock
New York
|
+$591K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$1.03M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$851K |
| 3 |
PCM
Patient Capital Management
Baltimore,
Maryland
|
-$801K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$551K |
| 5 |
D.E. Shaw & Co
New York
|
-$476K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CWM
151
Congress Wealth Management
Boston,
Massachusetts
| – | -$13.4K | -12,000 | Closed |
|
|
AWM
152
Avior Wealth Management
Omaha,
Nebraska
| – | -$280 | -250 | Closed |
|
|
TCOV
153
Trust Company of Vermont
Brattleboro,
Vermont
| – | -$224 | -200 | Closed |
|
154
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$196 | -175 | Closed |
|
PGEN Hedge Fund Activity: Q1 2025 in Review
138 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2025, worth a combined $124M — up 47% from $84.8M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new PGEN positions and 17 closed out — a net gain of 5 holders — while 34 added to existing stakes and 43 trimmed.
The largest buyer was Parkman Healthcare Partners, opening a new position worth an estimated $5.02M. The largest seller was Iridian Asset Management, cutting an estimated $1.03M.
- 138 institutional investors held Precigen (PGEN) as of Q1 2025, up from 133 in Q4 2024.
- Funds reported $124M of Precigen stock for Q1 2025, up 47% quarter-over-quarter.
- 22 funds opened new Precigen positions in Q1 2025 and 17 closed out, a net change of +5 holders.
- The largest Precigen buyer in Q1 2025 was Parkman Healthcare Partners, an estimated $5.02M added.
- The largest Precigen seller in Q1 2025 was Iridian Asset Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q1 2025.